What's Hot

    From crisis to catastrophe: China’s potential 65 million COVID cases per week by June

    May 30, 2023

    Twitter’s legal woes mount as former PR firm files lawsuit for unpaid invoices

    May 30, 2023

    India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite

    May 29, 2023
    Facebook Twitter Instagram
    Trending
    • From crisis to catastrophe: China’s potential 65 million COVID cases per week by June
    • Twitter’s legal woes mount as former PR firm files lawsuit for unpaid invoices
    • India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite
    • Global clean energy investment set to reach $1.7 trillion, overtaking oil production
    • European Investment Bank supports circular economy with €3.4 billion lending
    • WHO report urges governments: prioritize food security over tobacco industry
    • Successful UAE-India partnership stands as a model of bilateral cooperation
    • India soaring to new heights: the impact of nine years of Modi’s leadership
    • Home
    • Contact Us
    Riyadh ReportRiyadh Report
    Wednesday, May 31
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Riyadh ReportRiyadh Report
    Home » Japanese glucan supplement Nichi GLOW improves autism spectrum disorder behaviors

    Japanese glucan supplement Nichi GLOW improves autism spectrum disorder behaviors

    March 9, 2022

    MENA Newswire: March, 2022, Tokyo – In children with autism spectrum disorder (ASD), Beta 1,3 -1,6 glucan (Nichi GLOW) as an adjunct, when orally consumed with conventional therapies, yielded behavioral improvement, documented by Childhood Autism Rating Scale (CARS) score in a pilot clinical study, published in BMJ Neurology Open. Blood levels of Alpha-synuclein, a neurotransmitter and Melatonin increased along with improvement in sleep, learning skills and communication ability.

    Japanese glucan supplement Nichi GLOW improves autism spectrum disorder behaviors

    In the first of its kind report, in a study of 90-days, those who consumed AFO-202 strain of black yeast Aureobasidium Pullulans produced Beta 1,3 -1,6 glucan, had significant beneficial reconstitution of their gut microbiota than control group. Enterobacteria which produces harmful curli and amyloid proteins, causing misfolding of alpha-synuclein were controlled in the Nichi-GLOW group, is a breakthrough, said Dr Raghavan, developmental pediatrician, and neurologist, the first author. These harmful proteins aggregate in the neurons of the gut, propagate to brain through the gut-brain-axis like prions and could cause Parkinsons disease or Alzheimer’s later. This safe food supplement, addressing one of the root-causes by controlling enterobacteria is worth evaluating clinically as a prophylaxis to neurodegenerative diseases, he commented during an international webinar commemorating Autism Sunday.

    Mr. Takashi Onaka, who established the GMP scale exo-polysaccharide production of Nichi Glucan range of products, using the pristine waters of Nyodogawa river, in Kochi, Japan, appreciated the scientific pursuit of Prof. Noboru Fujii of Miyazaki University who explored the poly-extremotolerant nature of the Black yeast, upon isolating and successfully culturing it, in his lab in 1980s. A fungi evaluated for water purification has now evolved as a prebiotic food, with health benefits, he added. Dr Muralidhar Hegde from Houston Methodist Research Institute, USA, Prof. Nobunao Ikewaki from Kyushu University of Health and Welfare, Japan, and Dr Muzafar Gani Abdul Wahab of MacMaster University, Canada, joined the panel discussion.

    Nichi GLOW an approved food additive in Japan since 1996, doesn’t have any commonly known allergens. With a 25 years safety track record, though is not a drug or remedy to any illness, may serve as an adjunct in managing neurodevelopmental and neurodegenerative diseases after validation in different populations, according to the scientists. Clinical studies employing different strains of the product in unmet neurological diseases are underway.

    Keep Reading

    From crisis to catastrophe: China’s potential 65 million COVID cases per week by June

    Resting heart rate: The overlooked metric in cardiac health assessment

    New study highlights potential of Pfizer’s oral weight loss drug as alternative to Ozempic

    Exercise at certain times of the day increases longevity

    Apple Watch may soon offer no-prick glucose monitoring

    African leaders commit to ending AIDS among children by 2030

    Latest News

    From crisis to catastrophe: China’s potential 65 million COVID cases per week by June

    May 30, 2023

    Twitter’s legal woes mount as former PR firm files lawsuit for unpaid invoices

    May 30, 2023

    India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite

    May 29, 2023

    Global clean energy investment set to reach $1.7 trillion, overtaking oil production

    May 27, 2023

    European Investment Bank supports circular economy with €3.4 billion lending

    May 27, 2023

    WHO report urges governments: prioritize food security over tobacco industry

    May 27, 2023

    Successful UAE-India partnership stands as a model of bilateral cooperation

    May 27, 2023

    India soaring to new heights: the impact of nine years of Modi’s leadership

    May 25, 2023
    © 2021 Riyadh Report | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.